Company Filing History:
Years Active: 2017
Title: Jongjing Wang: Innovator in Pharmaceutical Composition for Parkinson's Disease
Introduction
Jongjing Wang is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Parkinson's disease. His innovative approach has led to the development of a unique pharmaceutical composition that addresses this challenging condition.
Latest Patents
Jongjing Wang holds 1 patent for his invention titled "Pharmaceutical composition for treating Parkinson's disease and preparation method thereof." This composition includes levodopa, carbidopa, and entacapone or pharmaceutically acceptable salts thereof. Notably, entacapone is not mixed with levodopa or carbidopa in the formulation. The preparation method involves creating first particles with levodopa and carbidopa, second particles with entacapone, and then pressing these particles into tablets.
Career Highlights
Jongjing Wang is currently employed at Innopharmax, Inc., where he continues to advance his research and development efforts in pharmaceuticals. His work is pivotal in creating effective treatments for patients suffering from Parkinson's disease.
Collaborations
Throughout his career, Jongjing has collaborated with talented coworkers such as Weihua Hao and Huiyun Chen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jongjing Wang's contributions to the pharmaceutical industry, particularly in the treatment of Parkinson's disease, highlight his role as an influential inventor. His innovative patent and ongoing work at Innopharmax, Inc. demonstrate his commitment to improving patient care through scientific advancements.